Drug Shortage Report for ERAXIS

Last updated on 2021-04-05 History
Report ID 136227
Drug Identification Number 02330695
Brand name ERAXIS
Common or Proper name ERAXIS
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) ANIDULAFUNGIN
Strength(s) 100MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 30mL vial
ATC code J02AX
ATC description ANTIMYCOTICS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-04-01
Estimated end date 2021-05-14
Actual end date
Shortage status Actual shortage
Updated date 2021-04-05
Company comments Inventory is on preventative allocation.
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2021-04-05 French Compare
v6 2021-04-05 English Compare
v5 2021-04-02 English Compare
v4 2021-03-31 French Compare
v3 2021-03-31 English Compare
v2 2021-03-25 French Compare
v1 2021-03-25 English Compare